May 2026
📣 VC round data is live. Check it out!
Largest Biopharmaceuticals Public Companies in Greece
Benchmark revenue and EBITDA valuation multiples for public comps like
Lavipharm and Medicon Hellas.
 | Lavipharm SA develops, manufactures, markets, and distributes pharmaceutical, cosmetic, and consumer health products in Greece and internationally. The company's product portfolio includes safe and effective therapeutic solutions that meet consumers' needs for health and well-being. Its main product categories are Cardiology, Oncology, Urology, Neurology, Psychiatry, General Medicine, Self-Treatment, and Dermocosmetic care. Its operating segments include Medicines, Parapharmaceuticals, and Services. | $2 | +107% | $326M | $357M | 4.9x | 21.0x | ||
| Medicon Hellas SA is a manufacturer of diagnostic reagent kits, and bulk reagents and a re-manufacturer of Olympus, Nihon Kohden, and Siemens analyzers. The company's services include Refurbishment, informatics, and Diagnostic Labs. | $3 | +13% | $14M | $14M | - | - | ||
| Median | $3 | +60% | $170M | $185M | 4.9x | 21.0x |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.